DE60141596D1 - Transdermales system zur verabreichung von loratadin und dessen verwendung - Google Patents
Transdermales system zur verabreichung von loratadin und dessen verwendungInfo
- Publication number
- DE60141596D1 DE60141596D1 DE60141596T DE60141596T DE60141596D1 DE 60141596 D1 DE60141596 D1 DE 60141596D1 DE 60141596 T DE60141596 T DE 60141596T DE 60141596 T DE60141596 T DE 60141596T DE 60141596 D1 DE60141596 D1 DE 60141596D1
- Authority
- DE
- Germany
- Prior art keywords
- transdermales
- loratadine
- administration
- urticariain
- tansdermal
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
- A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
- A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
- A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
- A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
- A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
- A61K47/38—Cellulose; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
- A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
- A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
- A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
- A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
- A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
- A61K9/7061—Polyacrylates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
- A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
- A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
- A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
- A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
- A61K9/7069—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained otherwise than by reactions only involving carbon to carbon unsaturated bonds, e.g. polysiloxane, polyesters, polyurethane, polyethylene oxide
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US24251500P | 2000-10-23 | 2000-10-23 | |
PCT/US2001/050205 WO2002058608A1 (en) | 2000-10-23 | 2001-10-23 | Loratadine transdermal device and methods |
Publications (1)
Publication Number | Publication Date |
---|---|
DE60141596D1 true DE60141596D1 (de) | 2010-04-29 |
Family
ID=22915072
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE60141596T Expired - Lifetime DE60141596D1 (de) | 2000-10-23 | 2001-10-23 | Transdermales system zur verabreichung von loratadin und dessen verwendung |
Country Status (6)
Country | Link |
---|---|
US (1) | US9259397B2 (de) |
EP (1) | EP1335689B1 (de) |
AT (1) | ATE460928T1 (de) |
DE (1) | DE60141596D1 (de) |
DK (1) | DK1335689T3 (de) |
WO (1) | WO2002058608A1 (de) |
Families Citing this family (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8790689B2 (en) | 2003-04-30 | 2014-07-29 | Purdue Pharma L.P. | Tamper resistant transdermal dosage form |
UA82880C2 (en) * | 2003-04-30 | 2008-05-26 | Tamper-resistant transdermal dosage form comprising an active agent component and an adverse agent component at the distal site of the active agent layer | |
DE10360592A1 (de) * | 2003-12-19 | 2005-07-28 | Beiersdorf Ag | Pflastersystem zur Verabreichung von Antihistaminika |
US20060229508A1 (en) * | 2005-03-30 | 2006-10-12 | Kermani Mahyar Z | Adhesive fluorescence measurement patch |
US20060224055A1 (en) * | 2005-03-30 | 2006-10-05 | Kermani Mahyar Z | Fluorescence measurement analytical kit |
US20060229507A1 (en) * | 2005-03-30 | 2006-10-12 | Kermani Mahyar Z | Adhesive fluorescence measurement band |
US20060224056A1 (en) * | 2005-03-30 | 2006-10-05 | Kermani Mahyar Z | Method for monitoring an implanted fluorescent light-emitting bead |
TWI825013B (zh) * | 2017-04-19 | 2023-12-11 | 日商帝國製藥股份有限公司 | 含有盧帕他定(rupatadine)之貼附劑 |
Family Cites Families (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
HU194864B (en) * | 1984-02-15 | 1988-03-28 | Schering Corp | Process for production of 8-chlor-6,11-dihydro-11-(4-piperidilidene)-5h-benzo (5,6)-cyclo-hepta (1,2-b) pyridine and its salts |
US5045319A (en) * | 1985-02-25 | 1991-09-03 | Rutgers, The State University Of New Jersey | Transdermal dosage unit, system and process |
US4910205A (en) * | 1988-05-02 | 1990-03-20 | Schering Corporation | Transdermal delivery of loratadine |
US5091186A (en) * | 1989-08-15 | 1992-02-25 | Cygnus Therapeutic Systems | Biphasic transdermal drug delivery device |
US5240711A (en) | 1989-11-29 | 1993-08-31 | Lts Lohmann Therapie-Systeme Gmbh & Co. Kg | Transdermal therapeutic system comprising as active component buprenorphine |
KR950005865B1 (ko) | 1990-04-23 | 1995-06-02 | 데이진 가부시끼가이샤 | 첩부제 |
DE4110027C2 (de) * | 1991-03-27 | 1996-08-29 | Lohmann Therapie Syst Lts | Verfahren zur Konfektionierung transdermaler therapeutischer Pflaster |
DE4442999A1 (de) * | 1994-12-02 | 1996-06-05 | Hexal Pharma Gmbh | Pharmazeutische Zusammensetzung mit einem aktiven Loratidin-Metaboliten |
DE4446600A1 (de) | 1994-12-24 | 1996-06-27 | Lohmann Therapie Syst Lts | Transdermale Resorption von Wirkstoffen aus unterkühlten Schmelzen |
WO1998018416A1 (en) * | 1996-10-30 | 1998-05-07 | Theratech, Inc. | Fatty acid esters of glycolic acid and its salts as permeation enhancers |
US5968547A (en) | 1997-02-24 | 1999-10-19 | Euro-Celtique, S.A. | Method of providing sustained analgesia with buprenorphine |
US5879701A (en) | 1997-02-28 | 1999-03-09 | Cygnus, Inc. | Transdermal delivery of basic drugs using nonpolar adhesive systems and acidic solubilizing agents |
US6103735A (en) * | 1998-10-09 | 2000-08-15 | Schering Corporation | Composition and method for treating allergic diseases |
-
2001
- 2001-10-23 DE DE60141596T patent/DE60141596D1/de not_active Expired - Lifetime
- 2001-10-23 WO PCT/US2001/050205 patent/WO2002058608A1/en active Application Filing
- 2001-10-23 DK DK01997122.5T patent/DK1335689T3/da active
- 2001-10-23 AT AT01997122T patent/ATE460928T1/de not_active IP Right Cessation
- 2001-10-23 US US10/045,607 patent/US9259397B2/en not_active Expired - Lifetime
- 2001-10-23 EP EP01997122A patent/EP1335689B1/de not_active Expired - Lifetime
Also Published As
Publication number | Publication date |
---|---|
ATE460928T1 (de) | 2010-04-15 |
EP1335689B1 (de) | 2010-03-17 |
WO2002058608A1 (en) | 2002-08-01 |
US9259397B2 (en) | 2016-02-16 |
EP1335689A4 (de) | 2005-02-09 |
DK1335689T3 (da) | 2010-06-14 |
EP1335689A1 (de) | 2003-08-20 |
US20030035828A1 (en) | 2003-02-20 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HUP0203529A2 (hu) | Dezloratadin alkalmazása alvászavarok kezelésére | |
DE60321929D1 (de) | Pharmazeutische zusammensetzungen mit dextromethorphan und chinidin zur behandlung von neurologischen erkrankungen | |
AR025964A1 (es) | Tratamiento nasal topico | |
DE60223715D1 (de) | Glyt1 transporter inhibitoren und deren anwendung in der behandlung von neurologischen und neuropsychiatischen krankheiten | |
DE60037394D1 (de) | VERWENDUNG VON p53 INHIBITOREN ZUR BEHANDLUNG VON NEBENERSCHEINUNGEN BEI DER KREBSTHERAPIE | |
DE60131775D1 (de) | Eine implantierbare oder einführbare vorrichtung zur abgabe therapeutischer mittel | |
DK1284656T3 (da) | Opretningsindretning til fremföring af en usymmetrisk indretning med en forudbestemt orientering | |
DE60109589D1 (de) | Pharmazeutische zusammensetzung zur behandlung von akutem schmerz, chronischem schmerz und/oder neuropathischem schmerz und migräne | |
ATE389649T1 (de) | Substituierte amin-derivate und deren verwendung zur behandlung von angionese-bedingten erkrankungen | |
DK0871473T3 (da) | Anvendelse af IL-10 til sårheling med reduceret ardannelse | |
ATE538807T1 (de) | Behandlung von sinusitis-assoziierten beschwerden mit botulinum toxin | |
ATE311200T1 (de) | Verfahren und zusammensetzungen zur behandlung von allergischen zuständen mit pgd2 rezeptor antagonisten | |
CY1107531T1 (el) | Χρηση αναστολεων πρωτεασομης για την αγωγη των διαταραχων ξηρου οφθαλμου | |
ATE312608T1 (de) | Cabergolin zur behandlung von fibromyalgie und chronic-fatigue-syndrom | |
BR0016138B1 (pt) | formulaÇço farmacÊutica adequada para a administraÇço intranasal, uso de zolmitriptan, e, dispositivo de administraÇço intranasal | |
NO20030677D0 (no) | Nye aporfinestere og deres anvendelse i terapi | |
DE60141596D1 (de) | Transdermales system zur verabreichung von loratadin und dessen verwendung | |
DE60206289D1 (de) | Verwendung von bibn4096 in kombination mit anderen migränemitteln zur behandlung von migräne | |
MY122838A (en) | Treating allergic and inflammatory conditions | |
EE05534B1 (et) | IL-18 inhibiitorite kasutamine ravimi valmistamiseks kardiomopaatia raviks ja/v?i ennetamiseks | |
DE60003550D1 (de) | Substituierte 3-pyridyl-4-arylpyrrole und deren einsatz in verfahren zur therapeutischen und prophylaktischen behandlung | |
TR200002939T2 (tr) | Paroksetin maleat | |
DE60219189D1 (de) | Iontophoretische okularvorrichtung zur abgabe von medikamenten auf methotrexat-basis und deren verwendung zur behandlung von neoplastischen, angiogenen, fibroplastischen und/oder immunsuppressiven augenunregelmässigkeiten | |
ATE291425T1 (de) | R-eliprodil zur behandlung von glaucoma | |
ATE236633T1 (de) | Topische verwendung von loperamid zur behandlung mikrobieller infektionen |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
8364 | No opposition during term of opposition |